A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.
Experimental Drug Acquiring Traction Via Social Media
Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to message these profiles directly for source information, while also receiving discount codes.
Active Commerce on Messaging Platforms
Additionally, a robust market exists on messaging services, where communities with thousands of participants share “before and after” photos, administration instructions and claims of rapid British shipping. Sellers market the drug there before directing buyers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.
Medical Experts Voice Concerns
Nevertheless, physicians and pharmacists have warned that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in users injecting substances of uncertain source.
Some experts stated the demand for the experimental drug could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.
Legal Position and Implementation
Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Some influencers try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach pharmaceutical, advertising, and consumer regulations, risking fines, legal action or imprisonment.
Service Response and Content Removal
According to the social media company, the platform has taken down problematic material and banned associated keywords and search suggestions. The company said it was dedicated to maintaining the service secure and allocating resources in enhancing compliance measures.
Digital Marketplace Activities
Research also found groups with up to nine thousand members selling retatrutide using the platform's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately displays channels with thousands of users, filled with images of slimming results, positive testimonials and step-by-step instructions for mixing or administering at home.
After minutes of joining one community, a vendor shared WhatsApp details, where most transactions take place. The vendor provided an guidebook and promised delivery within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one inquired about body mass, medical conditions or previous experience.
Product Information and Pricing
Inside these groups, posts show black plastic parcels with Royal Mail stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20mg. When questioned how long a pen should be used, vendors give contradictory answers varying between a several days to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for Telegram said it regularly monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are administering substances they can’t verify. Although the research behind retatrutide is valid, these online products may not include what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the increase in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But fake injections are highly risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained.
Her staff has previously encountered patients injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”
Producer Statement
A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company investigational product not yet approved … may subject patients to potentially significant medical dangers”.
